Slovenie Pyndiah
Inserm U955, Université Paris Est Créteil
Creteil, 94010, France
Creteil, 94010, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The Art of Domesticating Proteins: How Cancer Cells Adapt to Therapeutic and Environmental Stressors.
Journal: International journal of molecular sciences
Published: January 11, 2026
A new mechanism by which cancers can circumvent cisplatin resistance: The E2F1/BIN1 axis
Journal: Medecine sciences : M/S
Published: March 23, 2024
New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors.
Journal: International journal of molecular sciences
Published: October 13, 2021
Stressed ribosomes, a new pathway to promote oncogenesis used by EBNA1
Journal: Medecine sciences : M/S
Published: December 12, 2018
Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
Journal: The Journal of biological chemistry
Published: September 04, 2018
PI3Kδ activates E2F1 synthesis in response to mRNA translation stress.
Journal: Nature communications
Published: April 18, 2017
Restoration of tumor suppressor functions by small-molecule inhibitors.
Journal: Molecular & cellular oncology
Published: November 19, 2014
Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
Journal: The Journal of pathology
Published: June 16, 2014
Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation.
Journal: Cell death and differentiation
Published: May 19, 2014
c-MYC, PARP1 and BIN1 as targets for therapy of cancer cell resistance
Journal: Medecine sciences : M/S
Published: March 05, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026